Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34519801

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA
Publication date
2021 Sep 14
First author
Luo H

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2021 Nov 1;7(11):1613-1614. doi: 10.1001/jamaoncol.2021.4410.
    note
    Source null
    related pmid
    34519775
    relationship
    Comment in

Authors and identifiers

  1. name
    Luo H
    type
    Author
  2. name
    Lu J
    type
    Author
  3. name
    Bai Y
    type
    Author
  4. name
    Mao T
    type
    Author
  5. name
    Wang J
    type
    Author
  6. name
    Fan Q
    type
    Author
  7. name
    Zhang Y
    type
    Author
  8. name
    Zhao K
    type
    Author
  9. name
    Chen Z
    type
    Author
  10. name
    Gao S
    type
    Author
  11. name
    Li J
    type
    Author
  12. name
    Fu Z
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Luo H
    type
    Author
  2. name
    Lu J
    type
    Author
  3. name
    Bai Y
    type
    Author
  4. name
    Mao T
    type
    Author
  5. name
    Wang J
    type
    Author
  6. name
    Fan Q
    type
    Author
  7. name
    Zhang Y
    type
    Author
  8. name
    Zhao K
    type
    Author
  9. name
    Chen Z
    type
    Author
  10. name
    Gao S
    type
    Author
  11. name
    Li J
    type
    Author
  12. name
    Fu Z
    type
    Author
bibliography ids
  1. nci-bib-3faeb3fe76eaa7592df95313
book metadata
content sha256
16f6df362c0f39609deae52f3ce8a9d33a90817a74c61cc611084aedb05ddadc
document type
citation
dois
  1. 10.1001/jama.2021.12836
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:34519801
immutable id
pubmed:34519801@16f6df362c0f39609deae52f3ce8a9d33a90817a74c61cc611084aedb05ddadc
journal
abbreviation
JAMA
issn electronic
1538-3598
issn print
0098-7484
issue
10
name
JAMA
nlm unique id
7501160
pages
916-925
volume
326
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2021 Nov 1;7(11):1613-1614. doi: 10.1001/jamaoncol.2021.4410.
    note
    Source null
    related pmid
    34519775
    relationship
    Comment in
outcomes validated
false
pmid
34519801
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
dcebd45a50c08984e3e76da24ffaca4d4a490b2c8a593ccec0970ef5c83f3551
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Sep 14
precision
day
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34519801/
title
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial.

Preserved source evidence · Not medical advice